GENEVA, Sept. 7 -- SYSTIMMUNE, INC. filed a patent application (US2026/016765) for “LIGAND-NUCLIDE CONJUGATES AND THEIR USE THEREOF”. With publication no. WO/2026/183288, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....